Peanut Allergy Sublingual Immunotherapy: Your Complete Guide

What Is Peanut Allergy Sublingual Immunotherapy?

Peanut allergy sublingual immunotherapy (SLIT) is a treatment that involves placing small doses of peanut protein under the tongue to build tolerance over time. This approach trains the immune system to become less reactive to peanut allergens, potentially reducing the severity of allergic reactions upon accidental exposure.

How SLIT Differs From Avoidance

Unlike strict avoidance strategies, SLIT actively works to modify the body's immune response. The treatment uses gradually increasing doses of peanut protein to desensitize patients. This method offers a proactive approach for those managing common food allergies rather than simply avoiding triggers.

Key Benefits of Peanut SLIT

Peanut allergy sublingual immunotherapy provides several advantages for patients seeking treatment:

• Convenience — Doses can be administered at home after initial medical supervision
• Non-invasive — No needles required, making it suitable for children and needle-averse patients
• Gradual desensitization — Slowly builds tolerance to reduce reaction severity
• Improved quality of life — May decrease anxiety around accidental peanut exposure

How Does Sublingual Immunotherapy for Peanut Allergy Work?

Peanut allergy sublingual immunotherapy works by placing small, controlled doses of peanut protein extract under the tongue daily, where it's absorbed through the oral mucosa. This gradual exposure helps retrain the immune system to tolerate peanut proteins rather than triggering an allergic response.

The Desensitization Process

The treatment follows a carefully structured protocol that begins with extremely low doses. Over several months, these doses gradually increase to help the body build tolerance. This process is similar to how allergen-specific immunotherapy works for environmental allergies like pollen and dust mites.

What Happens During Treatment

Patients typically follow these steps during peanut SLIT:

• Hold the liquid extract under the tongue for 1-2 minutes before swallowing
• Take doses daily at home after the initial supervised phase
• Attend regular follow-up appointments to monitor progress and adjust dosing
• Continue maintenance therapy for an extended period to sustain tolerance

Who Is a Candidate for Peanut Allergy Sublingual Immunotherapy?

Candidates for peanut allergy sublingual immunotherapy are typically children and adults with confirmed IgE-mediated peanut allergies who want to reduce their risk of severe reactions from accidental exposure. Ideal candidates should be committed to daily treatment and have no uncontrolled asthma or other conditions that could complicate therapy.

Factors That Determine Eligibility

Healthcare providers evaluate several criteria when determining if someone is a good fit for peanut SLIT:

• Age requirements: Most clinical studies have focused on children ages 4 and older, though some adults may also qualify
• Allergy confirmation: A documented peanut allergy through skin prick testing or blood tests is essential
• Overall health status: Patients with well-controlled asthma and no history of severe anaphylaxis are generally better candidates
• Commitment level: Daily adherence to the treatment protocol is crucial for success

Who Should Avoid Peanut SLIT

Some individuals may not be suitable candidates for this treatment approach. Those with poorly controlled asthma face higher risks during immunotherapy. Patients who have experienced life-threatening anaphylactic reactions may need closer medical supervision or alternative treatment options. Your allergist will conduct a thorough evaluation to determine the safest path forward.

What Are the Results of Peanut Allergy Sublingual Immunotherapy?

The results of peanut allergy sublingual immunotherapy show promising outcomes for many patients. Studies demonstrate that SLIT can increase the threshold of peanut protein tolerated before a reaction occurs, reducing the risk of severe allergic responses from accidental exposure and improving quality of life.

Efficacy of SLIT for Treatment of Peanut Allergy

Clinical trials have shown measurable improvements in peanut tolerance among SLIT participants. Key findings include:

• Increased tolerance threshold: Many patients can tolerate significantly higher amounts of peanut protein after treatment
• Reduced reaction severity: When reactions do occur, they tend to be milder than before treatment
• Immune system changes: Blood tests often show decreased peanut-specific IgE levels and increased protective antibodies

While sublingual immunotherapy may not achieve the same desensitization levels as oral immunotherapy, it offers a favorable safety profile that makes it attractive for many families.

SLIT in Clinical Practice

Real-world application of peanut SLIT continues to evolve as more allergists incorporate it into their practices. Treatment protocols typically span several years, with patients taking daily doses under the tongue. Many families appreciate the convenience of allergy treatment without injections, allowing therapy to continue at home rather than requiring frequent office visits. Ongoing monitoring helps track progress and adjust dosing as needed.

What Are the Side Effects of Sublingual Immunotherapy for Peanut Allergy?

The side effects of sublingual immunotherapy for peanut allergy are typically mild and localized to the mouth and throat area. Most patients experience minor symptoms like itching or tingling under the tongue, which usually resolve within minutes and tend to decrease over time with continued treatment.

Safety of Peanut SLIT

Compared to other forms of immunotherapy, peanut SLIT demonstrates an excellent safety profile. Common side effects include:

• Oral itching or tingling
• Mild throat irritation
• Lip swelling
• Occasional gastrointestinal discomfort

Severe systemic reactions are rare with sublingual immunotherapy, making it a safer alternative to allergy shots. Most adverse events occur during the initial dosing phase and diminish as the body adjusts to treatment. Patients should still carry emergency epinephrine and know how to recognize signs of a more serious allergy rash or reaction. Healthcare providers typically recommend taking doses at home where patients can rest and monitor for any delayed responses.

How Does Sublingual Immunotherapy Compare to Other Peanut Allergy Treatments?

Sublingual immunotherapy differs from other peanut allergy treatments primarily in its administration method, safety profile, and convenience. While allergy shots require clinic visits and oral immunotherapy uses higher allergen doses, SLIT offers a middle ground with at-home dosing and fewer severe reactions, making it an attractive option for many patients.

Sublingual Allergy Drops Versus Allergy Shots

Allergy shots, or subcutaneous immunotherapy, have been used for decades to treat various allergies. However, they require frequent office visits and carry a higher risk of systemic reactions. Key differences between the two approaches include:

• Administration: SLIT drops are taken at home daily, while shots require in-office injections
• Safety: Sublingual drops have fewer severe reactions compared to injections
• Convenience: No need for regular clinic visits with SLIT
• Onset of action: Both methods require months to years for full effectiveness

Peanut Allergy Oral Immunotherapy

Oral immunotherapy (OIT) involves consuming gradually increasing amounts of peanut protein. While OIT can achieve higher levels of desensitization, it comes with more significant risks. Palforzia is the only FDA-approved OIT product for peanut allergy, but it requires careful medical supervision due to potential severe allergic reactions. SLIT uses smaller doses absorbed under the tongue, resulting in a gentler immune response with fewer gastrointestinal side effects than OIT.

Live Allergy-Free with Wyndly

If you want long-term relief from your allergies, Wyndly can help. Our doctors will help you identify your allergy triggers and create a personalized treatment plan to get you the lifelong relief you deserve. Start by taking our quick online allergy assessment today!

Frequently Asked Questions

How successful is oral immunotherapy for peanut allergies?

Oral immunotherapy for peanut allergies shows significant success, with studies indicating 67-85% of patients achieve desensitization. This means they can tolerate higher amounts of peanut protein without severe reactions. However, success varies by individual, and ongoing maintenance doses are typically required to maintain protection.

Why are they discontinuing Palforzia?

Aimmune Therapeutics discontinued Palforzia in 2023 due to poor commercial performance. The peanut allergy treatment faced challenges including complex dosing requirements, lengthy treatment protocols, high costs, and the need for patients to take doses under medical supervision, which limited widespread adoption and profitability.

What are the side effects of sublingual immunotherapy?

Common side effects of sublingual immunotherapy include mild itching or tingling in the mouth, throat irritation, and minor swelling under the tongue. Some people experience nausea or stomach discomfort. These reactions typically occur during the first few weeks and diminish as treatment continues. Severe reactions are rare.

What are the 9 major foods that cause 90% of allergic reactions?

The nine major food allergens responsible for 90% of allergic reactions are milk, eggs, peanuts, tree nuts, wheat, soy, fish, shellfish, and sesame. These allergens must be clearly labeled on packaged foods in the United States under federal food labeling laws.